196 related articles for article (PubMed ID: 24596400)
1. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
2. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
[TBL] [Abstract][Full Text] [Related]
3. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
4. [Incidence of breast cancer before and after implementation of mammography screening].
Hofvind S; Sørum R; Haldorsen T; Langmark F
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
6. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
7. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
[TBL] [Abstract][Full Text] [Related]
8. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme.
Sørum R; Hofvind S; Skaane P; Haldorsen T
Breast; 2010 Dec; 19(6):499-505. PubMed ID: 21071225
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
11. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer--incidence, mortality and stage shifting in Norway].
Zahl PH
Tidsskr Nor Laegeforen; 1997 Oct; 117(26):3765-7. PubMed ID: 9417678
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
15. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
[TBL] [Abstract][Full Text] [Related]
16. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
[TBL] [Abstract][Full Text] [Related]
17. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
[TBL] [Abstract][Full Text] [Related]
18. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.
Zahl PH; Strand BH; Maehlen J
BMJ; 2004 Apr; 328(7445):921-4. PubMed ID: 15013948
[TBL] [Abstract][Full Text] [Related]
19. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
20. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
